Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Fetal Electrocardiogram Helps Early Detection of Neonatal Acidosis

By HospiMedica International staff writers
Posted on 27 Jun 2011
A new study shows that a fetal electrocardiogram (FE) helps reduce cesarean incidence rate in women in labor at risk of losing fetal wellbeing, and also presents more advantages than pulse oximetry.

Researchers at the University of Granada conducted a study involving 180 women in labor who were admitted to the dilation area of the University Hospital Virgen de las Nieves (Granada, Spain). More...
The women were monitored with FE and with cardiotocographic recordings (CTG), which have been found to be compatible with the evaluation of risk of loss of fetal wellbeing.

The results showed that women who were monitored with FE had a lower cesarean delivery rate (30%) compared to CTG monitoring (46.7%), obtained better fetal Apgar test results, and also achieved better values in fetal umbilical cord gas analysis at birth than those recorded with pulse oximetry. The researchers also observed that FE providing more continuous information and a better signal, thus helping the obstetrician to control the state of the fetus via more accurate real-time monitoring. The results of the study were published in the June 2011 issue of the Spanish language journal Progresos en Ginecología y Obstetricia.

"Some people believe that both methods are equally effective and that they can be used in the same cases," said lead author Mercedes Valverde Pareja, a researcher at the department of gynecology and obstetrics at the University of Granada. "With this work, we found that their effectiveness is not the same, as they operate at different levels of fetal physiology and therefore give some very precise data. Furthermore, if compared, fetal electrocardiogram detects acidosis at an earlier stage, thus allowing them to have healthy fetuses."

Metabolic acidosis is defined as a low pH (lower than 7.35) due to an excess of acid or a deficit of base. Metabolic acidosis is a common finding in the sick newborn, generally due to stress during delivery; in some cases, the metabolic acidosis is acute, severe, and life threatening, as in shock. In other cases, the acidosis is mild, but persistent and, in still others, may be intermittent. The most common approach to metabolic acidosis in neonates is to correct the acidosis by administering bicarbonate.

Related Links:

University of Granada
University Hospital Virgen de las Nieves



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.